» Articles » PMID: 30645090

Crystal Structures of Fumarate Hydratases from Leishmania Major in a Complex with Inhibitor 2-Thiomalate

Overview
Journal ACS Chem Biol
Specialties Biochemistry
Biology
Date 2019 Jan 16
PMID 30645090
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Leishmaniases affect the poorest people on earth and have no effective drug therapy. Here, we present the crystal structure of the mitochondrial isoform of class I fumarate hydratase (FH) from Leishmania major and compare it to the previously determined cytosolic Leishmania major isoform. We further describe the mechanism of action of the first class-specific FH inhibitor, 2-thiomalate, through X-ray crystallography and inhibition assays. Our crystal structures of both FH isoforms with inhibitor bound at 2.05 Å resolution and 1.60 Å resolution show high structural similarity. These structures further reveal that the selectivity of 2-thiomalate for class I FHs is due to direct coordination of the inhibitor to the unique Fe of the catalytic [4Fe-4S] cluster that is found in class I parasitic FHs but is absent from class II human FH. These studies provide the structural scaffold in order to exploit class I FHs as potential drug targets against leishmaniases as well as Chagas diseases, sleeping sickness, and malaria.

Citing Articles

Aurothiomalate-Based Drugs as Potentially Novel Agents Against Leishmania major: A Mini Review.

Davoodi A, Eslami S, Fakhar M, Aazadbakht M, Montazeri M, Khoshvishkaie E Acta Parasitol. 2022; 67(2):640-647.

PMID: 35380401 DOI: 10.1007/s11686-022-00536-2.


Structural and Biochemical Investigations of the [4Fe-4S] Cluster-Containing Fumarate Hydratase from .

Feliciano P, Drennan C Biochemistry. 2019; 58(49):5011-5021.

PMID: 31743022 PMC: 7065722. DOI: 10.1021/acs.biochem.9b00923.

References
1.
Argaw D, Mulugeta A, Herrero M, Nombela N, Teklu T, Tefera T . Risk factors for visceral Leishmaniasis among residents and migrants in Kafta-Humera, Ethiopia. PLoS Negl Trop Dis. 2013; 7(11):e2543. PMC: 3820755. DOI: 10.1371/journal.pntd.0002543. View

2.
Coustou V, Biran M, Besteiro S, Riviere L, Baltz T, Franconi J . Fumarate is an essential intermediary metabolite produced by the procyclic Trypanosoma brucei. J Biol Chem. 2006; 281(37):26832-46. DOI: 10.1074/jbc.M601377200. View

3.
Field M, Horn D, Fairlamb A, Ferguson M, Gray D, Read K . Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing need. Nat Rev Microbiol. 2017; 15(4):217-231. PMC: 5582623. DOI: 10.1038/nrmicro.2016.193. View

4.
Pereira de Padua R, Nonato M . Cloning, expression, purification, crystallization and preliminary X-ray diffraction analysis of recombinant human fumarase. Acta Crystallogr F Struct Biol Commun. 2014; 70(Pt 1):120-2. PMC: 3943092. DOI: 10.1107/S2053230X13033955. View

5.
Otwinowski Z, Minor W . Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 1997; 276:307-26. DOI: 10.1016/S0076-6879(97)76066-X. View